The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Parkinson disease-associated cognitive impairment
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Self-citationRetractedThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Self-citationRelatives of the Impaired Elderly: Correlates of Feelings of Burden
Zarit, S. H., Reever, K. E., & Bach-Peterson, J. (1980) · The Gerontologist · doi:10.1093/geront/20.6.649 · Cited by 5,810
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Self-citationThe global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Self-citationA new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationJessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Chételat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.001 · Cited by 3,014
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationNichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30299-5 · Cited by 2,275
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Self-citationEvidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)
Lefaucheur, J.-P., Antal, A., Ayache, S. S., Benninger, D. H., Brunelin, J., Cogiamanian, F., Cotelli, M., De Ridder, D., Ferrucci, R., Langguth, B., et al. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.10.087 · Cited by 1,826
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Self-citationNeurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Diagnosis and Management of Dementia: Review
Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019) · JAMA · doi:10.1001/jama.2019.4782 · Cited by 1,403
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., & Weintraub, D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34b47 · Cited by 1,260
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Self-citationPeto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995) · Quality of Life Research · doi:10.1007/bf02260863 · Cited by 1,204
An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease
Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00005 · Cited by 1,194
Chaudhuri, K. R., Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., Brown, R. G., Koller, W., Barone, P., MacPhee, G., et al. (2006) · Movement Disorders · doi:10.1002/mds.20844 · Cited by 1,100
The Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,091
Chaudhuri, K. R., Martinez‐Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Abe, K., MacPhee, G., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,087
Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D., Duyckaerts, C., Cummings, J., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,082
Self-citationUpdate on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
Seppi, K., Ray Chaudhuri, K., Coelho, M., Fox, S. H., Katzenschlager, R., Perez Lloret, S., Weintraub, D., Sampaio, C., & and the collaborators of the Parkinson's Disease Update on Non‐Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence‐Based Medicine Committee (2019) · Movement Disorders · doi:10.1002/mds.27602 · Cited by 1,007
Self-citationMartinez‐Martin, P., Rodriguez‐Blazquez, C., Kurtis, M. M., Chaudhuri, K. R., & on Behalf of the NMSS Validation Group (2011) · Movement Disorders · doi:10.1002/mds.23462 · Cited by 989
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Self-citationThe distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Classification and Epidemiology of MCI
Roberts, R., & Knopman, D. S. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.003 · Cited by 839
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06891.x · Cited by 811
Self-citationResearch criteria for the diagnosis of prodromal dementia with Lewy bodies
McKeith, I. G., Ferman, T. J., Thomas, A. J., Blanc, F., Boeve, B. F., Fujishiro, H., Kantarci, K., Muscio, C., O'Brien, J. T., Postuma, R. B., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009323 · Cited by 777
Self-citationUpdate of the MDS research criteria for prodromal Parkinson's disease
Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., & the MDS Task Force on the Definition of Parkinson's Disease (2019) · Movement Disorders · doi:10.1002/mds.27802 · Cited by 768
Galasko, D. R., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. H. (1997) · PubMed · Cited by 767
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 748
Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis
Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f39d0e · Cited by 748
Self-citationBasal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline
Ballinger, E. C., Ananth, M., Talmage, D. A., & Role, L. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.006 · Cited by 730
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Self-citationDomains of cognition and their assessment
Harvey, P. D. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/pharvey · Cited by 695
Yamada, M., Mitsuno, S., Kato, S., & Hirano, H. (1997) · PubMed · Cited by 683
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams-Gray, C. H., Mason, S. L., Evans, J. R., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 681
Schneider, L. S., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, B., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 647
Burton, E. J. (2004) · Brain · doi:10.1093/brain/awh088 · Cited by 647
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G. (2009) · Neurology · doi:10.1212/01.wnl.0000338632.00552.cb · Cited by 625
Self-citationNeuropathologic substrates of Parkinson disease dementia
Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. ‐., Leverenz, J. B., Montine, T. J., Duda, J. E., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23659 · Cited by 518
Berg, D., Postuma, R. B., Bloem, B., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Hardy, J., Lang, A. E., et al. (2014) · Movement Disorders · doi:10.1002/mds.25844 · Cited by 506
Self-citationDauvilliers, Y., Schenck, C. H., Postuma, R. B., Iranzo, A., Luppi, P.-H., Plazzi, G., Montplaisir, J., & Boeve, B. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0016-5 · Cited by 492
The PDQ-8: Development and validation of a short-form parkinson's disease questionnaire
Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997) · Psychology & Health · doi:10.1080/08870449708406741 · Cited by 467
Aarsland, D., Ballard, C., Walker, Z., Bostrom, F., Alves, G., Kossakowski, K., Leroi, I., Pozo-Rodriguez, F., Minthon, L., & Londos, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70146-2 · Cited by 459
Self-citationDementia and survival in Parkinson disease: A 12-year population study
Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008) · Neurology · doi:10.1212/01.wnl.0000306632.43729.24 · Cited by 451
Self-citationChia, R., Sabir, M. S., Bandres-Ciga, S., Saez-Atienzar, S., Reynolds, R. H., Gustavsson, E., Walton, R. L., Ahmed, S., Viollet, C., Ding, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00785-3 · Cited by 438
Self-citationEmre, M., Tsolaki, M., Bonuccelli, U., Destée, A., Tolosa, E., Kutzelnigg, A., Ceballos-Baumann, A., Zdravkovic, S., Bladström, A., & Jones, R. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70194-0 · Cited by 436
Schrag, A., Siddiqui, U. F., Anastasiou, Z., Weintraub, D., & Schott, J. M. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30328-3 · Cited by 425
Self-citationThe Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T. S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 408
PD MED Collaborative Group (2014) · The Lancet · doi:10.1016/s0140-6736(14)60683-8 · Cited by 407
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., Goetz, C. G., Stebbins, G. T., Aarsland, D., & Alves, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.166 · Cited by 394
Self-citationBonanni, L., Thomas, A., Tiraboschi, P., Perfetti, B., Varanese, S., & Onofrj, M. (2008) · Brain · doi:10.1093/brain/awm322 · Cited by 379
Leroi, I., McDonald, K., Pantula, H., & Harbishettar, V. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712464823 · Cited by 378
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
Siderowf, A., Xie, S. X., Hurtig, H., Weintraub, D., Duda, J., Chen-Plotkin, A., Shaw, L. M., Van Deerlin, V., Trojanowski, J. Q., & Clark, C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f39a78 · Cited by 378
Self-citationMechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Bridi, J. C., & Hirth, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00080 · Cited by 378
Functions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-Cabronero, J., Callaghan, M. F., Lambert, C., Cardenas-Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 365
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
Ross, O. A., Yamada, M., Ramaswamy, S., Lippa, C. F., Tiraboschi, P., Kaufer, D., Mori, E., Montine, T. J., Masliah, E., Goldman, J. G., et al. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/8xge-z676 · Cited by 363
Self-citationMetabolic brain networks associated with cognitive function in Parkinson's disease
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M., & Eidelberg, D. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.003 · Cited by 361
Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work
Westbrook, A., van den Bosch, R., Määttä, J. I., Hofmans, L., Papadopetraki, D., Cools, R., & Frank, M. J. (2020) · Science · doi:10.1126/science.aaz5891 · Cited by 356
Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
Verschuur, C. V. M., Suwijn, S. R., Boel, J. A., Post, B., Bloem, B. R., van Hilten, J. J., van Laar, T., Tissingh, G., Munts, A. G., Deuschl, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809983 · Cited by 353
Risk factors for non-motor symptoms in Parkinson's disease
Marinus, J., Zhu, K., Marras, C., Aarsland, D., & van Hilten, J. J. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30127-3 · Cited by 348
Self-citationNew evidence on the management of Lewy body dementia
Taylor, J.-P., McKeith, I. G., Burn, D. J., Boeve, B. F., Weintraub, D., Bamford, C., Allan, L. M., Thomas, A. J., & O'Brien, J. T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30153-x · Cited by 347
Self-citationParkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease
Pagonabarraga, J., Kulisevsky, J., Llebaria, G., García‐Sánchez, C., Pascual‐Sedano, B., & Gironell, A. (2008) · Movement Disorders · doi:10.1002/mds.22007 · Cited by 344
Assessment of cognition in Parkinson’s disease
Marinus, J., Visser, M., Verwey, N. A., Verhey, F. R. J., Middelkoop, H. A. M., Stiggelbout, A. M., & van Hilten, J. J. (2003) · Neurology · doi:10.1212/01.wnl.0000091864.39702.1c · Cited by 339
Prevalence and Clinical Aspects of Mild Cognitive Impairment in Parkinson's Disease: A Meta‐Analysis
Baiano, C., Barone, P., Trojano, L., & Santangelo, G. (2020) · Movement Disorders · doi:10.1002/mds.27902 · Cited by 335
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease
Gagnon, J., Vendette, M., Postuma, R. B., Desjardins, C., Massicotte‐Marquez, J., Panisset, M., & Montplaisir, J. (2009) · Annals of Neurology · doi:10.1002/ana.21680 · Cited by 325
Cognitive training in Parkinson disease: A systematic review and meta-analysis
Leung, I. H. K., Walton, C. C., Hallock, H., Lewis, S. J. G., Valenzuela, M., & Lampit, A. (2015) · Neurology · doi:10.1212/wnl.0000000000002145 · Cited by 309
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Weintraub, D., Simuni, T., Caspell‐Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L. M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26170 · Cited by 305
Self-citationHall, H., Reyes, S., Landeck, N., Bye, C., Leanza, G., Double, K., Thompson, L., Halliday, G., & Kirik, D. (2014) · Brain · doi:10.1093/brain/awu193 · Cited by 302
Self-citationCortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 297
Self-citationThe Rate of Cognitive Decline in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Perry, R., Wentzel-Larsen, T., Lolk, A., & Kragh-Sørensen, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1906 · Cited by 283
Self-citationMaillet, A., Krack, P., Lhommée, E., Météreau, E., Klinger, H., Favre, E., Le Bars, D., Schmitt, E., Bichon, A., Pelissier, P., et al. (2016) · Brain · doi:10.1093/brain/aww162 · Cited by 282
Van der Perren, A., Gelders, G., Fenyi, A., Bousset, L., Brito, F., Peelaerts, W., Van den Haute, C., Gentleman, S., Melki, R., & Baekelandt, V. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02157-3 · Cited by 277
Ravina, B. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.050682 · Cited by 273
Wang, H.-F., Yu, J.-T., Tang, S.-W., Jiang, T., Tan, C.-C., Meng, X.-F., Wang, C., Tan, M.-S., & Tan, L. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307659 · Cited by 269
Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study
Pedersen, K. F., Larsen, J. P., Tysnes, O.-B., & Alves, G. (2017) · Neurology · doi:10.1212/wnl.0000000000003634 · Cited by 267
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
Jellinger, K. A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1821-9 · Cited by 264
Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5465-z · Cited by 256
Schaser, A. J., Osterberg, V. R., Dent, S. E., Stackhouse, T. L., Wakeham, C. M., Boutros, S. W., Weston, L. J., Owen, N., Weissman, T. A., Luna, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47227-z · Cited by 256
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255
Self-citationEhrt, U., Broich, K., Larsen, J. P., Ballard, C., & Aarsland, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.186239 · Cited by 254
Self-citationLongitudinal study of normal cognition in Parkinson disease
Pigott, K., Rick, J., Xie, S. X., Hurtig, H., Chen-Plotkin, A., Duda, J. E., Morley, J. F., Chahine, L. M., Dahodwala, N., Akhtar, R. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002001 · Cited by 251
Self-citationMarra, D. E., Hamlet, K. M., Bauer, R. M., & Bowers, D. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1769192 · Cited by 251
Frankemolle, A. M. M., Wu, J., Noecker, A. M., Voelcker-Rehage, C., Ho, J. C., Vitek, J. L., McIntyre, C. C., & Alberts, J. L. (2010) · Brain · doi:10.1093/brain/awp315 · Cited by 250
Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 231
Global scales for cognitive screening in Parkinson's disease: Critique and recommendations
Skorvanek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorova, I., Schmand, B., van Duijn, E., Goetz, C. G., Weintraub, D., Stebbins, G. T., et al. (2018) · Movement Disorders · doi:10.1002/mds.27233 · Cited by 229
Self-citationRandomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
Leroi, I., Brandt, J., Reich, S. G., Lyketsos, C. G., Grill, S., Thompson, R., & Marsh, L. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.993 · Cited by 226
Histologic validation of locus coeruleus MRI contrast in post-mortem tissue
Keren, N. I., Taheri, S., Vazey, E. M., Morgan, P. S., Granholm, A.-C. E., Aston-Jones, G. S., & Eckert, M. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.03.020 · Cited by 225
Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease
Martinez-Martin, P., Rodriguez-Blazquez, C., Forjaz, M. J., Frades-Payo, B., Agüera-Ortiz, L., Weintraub, D., Riesco, A., Kurtis, M. M., & Chaudhuri, K. R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.03.024 · Cited by 222
Self-citationClinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
Qamhawi, Z., Towey, D., Shah, B., Pagano, G., Seibyl, J., Marek, K., Borghammer, P., Brooks, D. J., & Pavese, N. (2015) · Brain · doi:10.1093/brain/awv215 · Cited by 218
Sommerauer, M., Fedorova, T. D., Hansen, A. K., Knudsen, K., Otto, M., Jeppesen, J., Frederiksen, Y., Blicher, J. U., Geday, J., Nahimi, A., et al. (2018) · Brain · doi:10.1093/brain/awx348 · Cited by 216
Quantitative EEG as a predictive biomarker for Parkinson disease dementia
Klassen, B. T., Hentz, J. G., Shill, H. A., Driver-Dunckley, E., Evidente, V. G. H., Sabbagh, M. N., Adler, C. H., & Caviness, J. N. (2011) · Neurology · doi:10.1212/wnl.0b013e318224af8d · Cited by 214
Witt, K., Granert, O., Daniels, C., Volkmann, J., Falk, D., van Eimeren, T., & Deuschl, G. (2013) · Brain · doi:10.1093/brain/awt151 · Cited by 211
The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder
Ehrminger, M., Latimier, A., Pyatigorskaya, N., Garcia-Lorenzo, D., Leu-Semenescu, S., Vidailhet, M., Lehericy, S., & Arnulf, I. (2016) · Brain · doi:10.1093/brain/aww006 · Cited by 211
Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
Petrou, M., Dwamena, B. A., Foerster, B. R., MacEachern, M. P., Bohnen, N. I., Müller, M. L., Albin, R. L., & Frey, K. A. (2015) · Movement Disorders · doi:10.1002/mds.26191 · Cited by 208
Schulz, J., Pagano, G., Fernández Bonfante, J. A., Wilson, H., & Politis, M. (2018) · Brain · doi:10.1093/brain/awy072 · Cited by 208
Ray, N. J., Bradburn, S., Murgatroyd, C., Toseeb, U., Mir, P., Kountouriotis, G. K., Teipel, S. J., & Grothe, M. J. (2018) · Brain · doi:10.1093/brain/awx310 · Cited by 207
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Buddhala, C., Loftin, S. K., Kuley, B. M., Cairns, N. J., Campbell, M. C., Perlmutter, J. S., & Kotzbauer, P. T. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.246 · Cited by 206
Noradrenergic Modulation of Cognition in Health and Disease
Borodovitsyna, O., Flamini, M., & Chandler, D. (2017) · Neural Plasticity · doi:10.1155/2017/6031478 · Cited by 205
Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
Lawson, R. A., Yarnall, A. J., Duncan, G. W., Breen, D. P., Khoo, T. K., Williams-Gray, C. H., Barker, R. A., Collerton, D., Taylor, J.-P., & Burn, D. J. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.04.009 · Cited by 204
The Effects of Physical Activity in Parkinson’s Disease: A Review
Lauzé, M., Daneault, J.-F., & Duval, C. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160790 · Cited by 204
Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
Dubois, B., Tolosa, E., Katzenschlager, R., Emre, M., Lees, A. J., Schumann, G., Pourcher, E., Gray, J., Thomas, G., Swartz, J., et al. (2012) · Movement Disorders · doi:10.1002/mds.25098 · Cited by 202
Evolution of mild cognitive impairment in Parkinson disease
Broeders, M., de Bie, R. M. A., Velseboer, D. C., Speelman, J. D., Muslimovic, D., & Schmand, B. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5c86 · Cited by 200
Smith, C., Malek, N., Grosset, K., Cullen, B., Gentleman, S., & Grosset, D. G. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321111 · Cited by 198
Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study
Pedersen, K. F., Larsen, J. P., Alves, G., & Aarsland, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.006 · Cited by 194
Self-citationAn introduction to the concept of “quality of life in Parkinson’s disease”
Martínez-Martín, P. (1998) · Journal of Neurology · doi:10.1007/pl00007733 · Cited by 191
Mollenhauer, B., Zimmermann, J., Sixel‐Döring, F., Focke, N. K., Wicke, T., Ebentheuer, J., Schaumburg, M., Lang, E., Friede, T., Trenkwalder, C., et al. (2019) · Movement Disorders · doi:10.1002/mds.27492 · Cited by 191
Mild cognitive impairment as a risk factor for Parkinson's disease dementia
Hoogland, J., Boel, J. A., de Bie, R. M. A., Geskus, R. B., Schmand, B. A., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Goldman, J. G., Tröster, A. I., et al. (2017) · Movement Disorders · doi:10.1002/mds.27002 · Cited by 189
Self-citationda Silva, F. C., Iop, R. D. R., de Oliveira, L. C., Boll, A. M., de Alvarenga, J. G. S., Gutierres Filho, P. J. B., de Melo, L. M. A. B., Xavier, A. J., & da Silva, R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193113 · Cited by 189
Toledo, J. B., Gopal, P., Raible, K., Irwin, D. J., Brettschneider, J., Sedor, S., Waits, K., Boluda, S., Grossman, M., Van Deerlin, V. M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1526-9 · Cited by 184
Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease
Weintraub, D., Dietz, N., Duda, J. E., Wolk, D. A., Doshi, J., Xie, S. X., Davatzikos, C., Clark, C. M., & Siderowf, A. (2012) · Brain · doi:10.1093/brain/awr277 · Cited by 180
Self-citationLiu, G., Locascio, J. J., Corvol, J.-C., Boot, B., Liao, Z., Page, K., Franco, D., Burke, K., Jansen, I. E., Trisini-Lipsanopoulos, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30122-9 · Cited by 180
Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
Domellöf, M., Ekman, U., Forsgren, L., & Elgh, E. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12375 · Cited by 176
Predictors of Survival in Patients With Parkinson Disease
Schootman, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2370 · Cited by 175
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study
Bäckström, D., Granåsen, G., Domellöf, M. E., Linder, J., Jakobson Mo, S., Riklund, K., Zetterberg, H., Blennow, K., & Forsgren, L. (2018) · Neurology · doi:10.1212/wnl.0000000000006576 · Cited by 174
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
Chahine, L. M., Beach, T. G., Brumm, M. C., Adler, C. H., Coffey, C. S., Mosovsky, S., Caspell‐Garcia, C., Serrano, G. E., Muñoz, D. G., White, C. L., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010404 · Cited by 173
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
Orgeta, V., McDonald, K. R., Poliakoff, E., Hindle, J. V., Clare, L., & Leroi, I. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011961.pub2 · Cited by 171
Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
Saredakis, D., Collins‐Praino, L. E., Gutteridge, D. S., Stephan, B. C. M., & Keage, H. A. D. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.04.020 · Cited by 171
Iwaki, H., Blauwendraat, C., Leonard, H. L., Kim, J. J., Liu, G., Maple‐Grødem, J., Corvol, J., Pihlstrøm, L., van Nimwegen, M., Hutten, S. J., et al. (2019) · Movement Disorders · doi:10.1002/mds.27845 · Cited by 170
Self-citationPlasma α-synuclein predicts cognitive decline in Parkinson’s disease
Lin, C., Yang, S., Horng, H. E., Yang, C., Chieh, J.-J., Chen, H.-H., Liu, B.-H., & Chiu, M. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314857 · Cited by 168
Bohnen, N. I., Albin, R. L., Müller, M. L. T. M., Petrou, M., Kotagal, V., Koeppe, R. A., Scott, P. J. H., & Frey, K. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2757 · Cited by 167
Lee, J. E., Cho, K. H., Song, S. K., Kim, H. J., Lee, H. S., Sohn, Y. H., & Lee, P. H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305062 · Cited by 165
Measuring mild cognitive impairment in patients with Parkinson's disease
Marras, C., Armstrong, M. J., Meaney, C. A., Fox, S. H., Rothberg, B., Reginold, W., Tang‐Wai, D. F., Gill, D., Eslinger, P. J., Zadikoff, C., et al. (2013) · Movement Disorders · doi:10.1002/mds.25426 · Cited by 162
Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease
París, A. P., Saleta, H. G., de la Cruz Crespo Maraver, M., Silvestre, E., Freixa, M. G., Torrellas, C. P., Pont, S. A., Nadal, M. F., Garcia, S. A., Bartolomé, M. V. P., et al. (2011) · Movement Disorders · doi:10.1002/mds.23688 · Cited by 160
Manenti, R., Brambilla, M., Benussi, A., Rosini, S., Cobelli, C., Ferrari, C., Petesi, M., Orizio, I., Padovani, A., Borroni, B., et al. (2016) · Movement Disorders · doi:10.1002/mds.26561 · Cited by 160
Genome‐Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease
Tan, M. M. X., Lawton, M. A., Jabbari, E., Reynolds, R. H., Iwaki, H., Blauwendraat, C., Kanavou, S., Pollard, M. I., Hubbard, L., Malek, N., et al. (2021) · Movement Disorders · doi:10.1002/mds.28342 · Cited by 160
Targeting impulsivity in Parkinson’s disease using atomoxetine
Kehagia, A. A., Housden, C. R., Regenthal, R., Barker, R. A., Müller, U., Rowe, J. B., Sahakian, B. J., & Robbins, T. W. (2014) · Brain · doi:10.1093/brain/awu117 · Cited by 159
Caspell-Garcia, C., Simuni, T., Tosun-Turgut, D., Wu, I.-W., Zhang, Y., Nalls, M., Singleton, A., Shaw, L. A., Kang, J.-H., Trojanowski, J. Q., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175674 · Cited by 159
Self-citationDementia in low-income and middle-income countries: Different realities mandate tailored solutions
Ferri, C. P., & Jacob, K. S. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002271 · Cited by 154
Gratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., Day, B. L., Mancini, L., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3762 · Cited by 154
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Henderson, M. X., Sedor, S. F., McGeary, I., Cornblath, E. J., Peng, C., Riddle, D. M., Li, H. L., Zhang, B., Brown, H. J., Olufemi, M. F., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.12.004 · Cited by 152
Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?
McDonald, C., Newton, J. L., & Burn, D. J. (2016) · Movement Disorders · doi:10.1002/mds.26632 · Cited by 151
Mattila, P. M., Röyttä, M., Lönnberg, P., Marjamäki, P., Helenius, H. Y. M., & Rinne, J. O. (2001) · Acta Neuropathologica · doi:10.1007/s004010100372 · Cited by 150
Litvinenko, I., Odinak, M. M., Mogil'naia, V. I., & Emelin, А. Y. (2008) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-008-9077-3 · Cited by 144
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
McFarthing, K., Buff, S., Rafaloff, G., Dominey, T., Wyse, R. K. H., & Stott, S. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202128 · Cited by 144
The economic impact of cognitive impairment in Parkinson's disease
Vossius, C., Larsen, J. O., Janvin, C. C., & Aarsland, D. (2011) · Movement Disorders · doi:10.1002/mds.23661 · Cited by 142
Self-citationValera, E., Spencer, B. J., & Masliah, E. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0397-z · Cited by 141
Randomized controlled trial of memantine in dementia associated with Parkinson's disease
Leroi, I., Overshott, R., Byrne, E. J., Daniel, E., & Burns, A. S. (2009) · Movement Disorders · doi:10.1002/mds.22495 · Cited by 140
The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study
Chaudhuri, К. R., Schrag, A. E., Weintraub, D. A., Rizos, A., Rodríguez‐Blázquez, C., Mamikonyan, E., & Martínez‐Martín, P. (2019) · Movement Disorders · doi:10.1002/mds.27862 · Cited by 139
Self-citationStability of mild cognitive impairment in newly diagnosed Parkinson's disease
Lawson, R. A., Yarnall, A. J., Duncan, G. W., Breen, D. P., Khoo, T. K., Williams‐Gray, C. H., Barker, R. A., & Burn, D. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315099 · Cited by 137
Effects of orthostatic hypotension on cognition in Parkinson disease
Centi, J., Freeman, R. L., Gibbons, C. H., Neargarder, S. A., Canova, A. O., & Cronin‐Golomb, A. (2016) · Neurology · doi:10.1212/wnl.0000000000003452 · Cited by 132
Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo‐controlled study
Mamikonyan, E., Xie, S. X., Melvin, E., & Weintraub, D. A. (2015) · Movement Disorders · doi:10.1002/mds.26236 · Cited by 131
Self-citationCognitive changes in prodromal Parkinson's disease: A review
Fengler, S., Liepelt‐Scarfone, I., Brockmann, K., Schäffer, E., Berg, D., & Kalbe, E. (2017) · Movement Disorders · doi:10.1002/mds.27135 · Cited by 131
Chung, S. W., Sullivan, C. M., Rogasch, N. C., Hoy, K. E., Bailey, N. W., Cash, R. F. H., & Fitzgerald, P. B. (2018) · Human Brain Mapping · doi:10.1002/hbm.24398 · Cited by 131
Cellular and molecular pathophysiology in the progression of Parkinson’s disease
Zaman, V., Shields, D. C., Shams, R., Drasites, K. P., Matzelle, D. D., Haque, A., & Banik, N. L. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00689-5 · Cited by 129
Seeding variability of different alpha synuclein strains in synucleinopathies
Candelise, N., Schmitz, M., Llorens, F., Villar‐Piqué, A., Cramm, M., Thom, T., Correia, S., da Cunha, J. E. G., Möbius, W., Outeiro, T. F., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25446 · Cited by 128
Hanagasi, H. A., Gurvit, H. I., Unsalan, P., Horozoğlu, H., Tuncer, N., Feyzioğlu, A., Günal, D. İ., Yener, G., Çakmur, R., Sahin, H. A., et al. (2011) · Movement Disorders · doi:10.1002/mds.23738 · Cited by 124
Power, J. H. T., Barnes, O. L., & Chegini, F. (2017) · Brain Pathology · doi:10.1111/bpa.12344 · Cited by 120
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 120
Stephan, B. C. M., Pakpahan, E., Siervo, M., Licher, S., Terrera, G. M., Mohan, D., Acosta, D. M., Pichardo, G. R., Sosa, A. L., Acosta, I., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30062-0 · Cited by 119
Pagano, G., Niccolini, F., Fusar‐Poli, P., & Politis, M. (2016) · Annals of Neurology · doi:10.1002/ana.24859 · Cited by 117
Chahine, L. M., Weintraub, D. A., Hawkins, K. A., Siderowf, A. D., Eberly, S. W., Oakes, D., Seibyl, J. P., Stern, M. B., MAREK, K. L., Jennings, D. L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26373 · Cited by 116
Self-citationLongitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease
Pereira, J. B., Hall, S., Jalakas, M., Grothe, M. J., Strandberg, O. T., Stomrud, E., Westman, E., van Westen, D., & Hansson, O. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104831 · Cited by 112
Biomarkers of cognitive decline in Parkinson's disease
Lin, C., & Wu, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.010 · Cited by 111
Kulisevsky, J., de Bobadilla, R. F., Pagonabarraga, J., Martínez‐Horta, S., Campolongo, A., García‐Sánchez, C., Pascual‐Sedano, B., Nogué, R. R., & Villa-Bonomo, C. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.007 · Cited by 109
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease?
Erro, R., Santangelo, G., Barone, P., Picillo, M., Amboni, M., Longo, K., Giordano, F., Moccia, M., Allocca, R., Pellecchia, M. T., et al. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714532015 · Cited by 109
Public involvement in health and social sciences research: A concept analysis
Hughes, M., & Duffy, C. M. (2018) · Health Expectations · doi:10.1111/hex.12825 · Cited by 109
Betrouni, N., Delval, A., Chaton, L., Defebvre, L., Duits, A., Moonen, A. J. H., Leentjens, A. F. G., & Dujardin, K. (2018) · Movement Disorders · doi:10.1002/mds.27528 · Cited by 109
Gaykema, R. P. A., & Záborszky, L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961028)374:4<555::aid-cne6>3.0.co;2-0 · Cited by 103
Zhang, Y., Wu, I.-W., Tosun, D., Foster, E., Schuff, N. W., & Initiative, T. P. P. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165540 · Cited by 103
Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
Horne, K., Myall, D. J., Livingston, L., Melzer, T. R., Pitcher, T. L., MacAskill, M. R., Geurtsen, G. J., Anderson, T., & Dalrymple‐Alford, J. C. (2016) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.27 · Cited by 102
Self-citationYu, J., Yap, P. L. K., & Liew, T. M. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1450841 · Cited by 102
α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
Guella, I., Evans, D. M., Szu‐Tu, C., Nosova, E., Bortnick, S., SNCA Cognition Study Group, Goldman, J. G., Dalrymple‐Alford, J. C., Geurtsen, G. J., Litvan, I., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24664 · Cited by 101
Self-citationPaciotti, S., Bellomo, G., Gatticchi, L., & Parnetti, L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00415 · Cited by 101
Lawrence, B. J., Gasson, N., Bucks, R. S., Troeung, L., & Loftus, A. M. (2017) · Neurorehabilitation and neural repair · doi:10.1177/1545968317712468 · Cited by 98
Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease
Winer, J. R., Maaß, A., Pressman, P., Stiver, J., Schonhaut, D. R., Baker, S. L., Kramer, J. H., Rabinovici, G. D., & Jagust, W. J. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3713 · Cited by 95
Lawrence, B. J., Gasson, N., Johnson, A. R., Booth, L., & Loftus, A. M. (2018) · Parkinson s Disease · doi:10.1155/2018/4318475 · Cited by 94
Li, Y., Wang, C., Wang, J., Zhou, Y., Ye, F., Zhang, Y., Cheng, X., Huang, Z., Liu, K., Fei, G., et al. (2019) · Movement Disorders · doi:10.1002/mds.27682 · Cited by 94
Advances in the treatment of cognitive impairment in P arkinson's disease
Goldman, J. G., & Weintraub, D. A. (2015) · Movement Disorders · doi:10.1002/mds.26352 · Cited by 89
Self-citationNeuroinflammation in dementia with Lewy bodies: a human post-mortem study
Amin, J., Holmes, C., Dorey, R. B., Tommasino, E., Casal, Y. R., Williams, D. M., Dupuy, C., Nicoll, J. A. R., & Boche, D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00954-8 · Cited by 89
Kamińska, M., Mery, V., Lafontaine, A., Robinson, A. R., Benedetti, A., Gros, P., & Kimoff, R. J. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7114 · Cited by 88
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
Melzer, T. R., Stark, M. R., Keenan, R. J., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Grenfell, S., Horne, K., Young, B., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00391 · Cited by 88
Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies
Smirnov, D. S., Galasko, D. R., Edland, S. D., Filoteo, J. V., Hansen, L. A., & Salmon, D. P. (2020) · Neurology · doi:10.1212/wnl.0000000000009434 · Cited by 88
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Weintraub, D. A., Caspell‐Garcia, C., Simuni, T., Cho, H. R., Coffey, C. S., Aarsland, D., Alcalay, R. N., Barrett, M. J., Chahine, L. M., Eberling, J. L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51022 · Cited by 87
Self-citationLi, Z., Wang, P., Yu, Z., Cong, Y., Sun, H., Zhang, J., Zhang, J., Sun, C., Zhang, Y., & Ju, X. (2015) · European Neurology · doi:10.1159/000377676 · Cited by 86
Coenzyme Q and Its Role in the Dietary Therapy against Aging
Varela-López, A., Giampieri, F., Battino, M., & Quiles, J. (2016) · Molecules · doi:10.3390/molecules21030373 · Cited by 86
Can neuroimaging predict dementia in Parkinson’s disease?
Lanskey, J. H., McColgan, P., Schrag, A. E., Acosta‐Cabronero, J., Rees, G. E., Morris, H. R., & Weil, R. S. (2018) · Brain · doi:10.1093/brain/awy211 · Cited by 84
Hoogland, J., van Wanrooij, L. L., Boel, J. A., Goldman, J. G., Stebbins, G. T., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Junqué, C., Pedersen, K. F., et al. (2018) · Movement Disorders · doi:10.1002/mds.110 · Cited by 82
Self-citationArguing against the proposed definition changes of PD
Boeve, B. F., Dickson, D. W., Duda, J. E., Ferman, T. J., Galasko, D. R., Galvin, J. E., Goldman, J. G., Growdon, J. H., Hurtig, H. I., Kaufer, D., et al. (2016) · Movement Disorders · doi:10.1002/mds.26721 · Cited by 81
Self-citationBiundo, R., Weis, L., Fiorenzato, E., Gentile, G., Giglio, M., Schifano, R., Campo, M. C., Marcon, V., Martinez-Martin, P., Bisiacchi, P., et al. (2015) · Brain Stimulation · doi:10.1016/j.brs.2015.07.043 · Cited by 79
Parkinson’s Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care
Williams, U. E., Bandmann, O., & Walker, R. W. (2018) · Journal of Movement Disorders · doi:10.14802/jmd.17028 · Cited by 79
Ma, K., Song, L.-K., Yuan, Y., Zhang, Y., Han, N., Gao, K., & Chen, N. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.035 · Cited by 76
Gargouri, F., Galléa, C., Mongin, M., Pyatigorskaya, N., Valabrègue, R., Ewenczyk, C., Sarazin, M., Yahia‐Cherif, L., Vidailhet, M., & Lehéricy, S. (2018) · Movement Disorders · doi:10.1002/mds.27561 · Cited by 76
Long-term Safety of Rivastigmine in Parkinson Disease Dementia
Emre, M., Poewe, W. H., Deyn, P. P. D., et al. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000010 · Cited by 74
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo‐controlled trial
Weintraub, D. A., Hauser, R. A., Elm, J. J., Pagán, F., Davis, M. D., Choudhry, A., & for the MODERATO Investigators (2016) · Movement Disorders · doi:10.1002/mds.26617 · Cited by 74
Self-citationBrennan, L., Siderowf, A. D., Rubright, J. D., Rick, J. H., Dahodwala, N. A., Duda, J. E., Hurtig, H. I., Stern, M., Xie, S. X., Rennert, L., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.020 · Cited by 73
Self-citation
Cited by
Afzal, S., Abdul Manap, A. S., Attiq, A., Albokhadaim, I., Kandeel, M., & Alhojaily, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 416
Yen, C., Lin, C.-L., & Chiang, M.-C. (2023) · Life · doi:10.3390/life13071472 · Cited by 281
Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
Yu, J. E., Yeo, I. J., Han, S.-B., Yun, J., Kim, B., Yong, Y. J., Lim, Y.-S., Kim, T. H., Son, D. J., & Hong, J. T. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01131-9 · Cited by 109
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
“302,303 The primary clinical symptom of PD is motor impairment, in addition to non-motor de fi cits including cognitive decline, 304,305 depression, and pain, which greatly affect the quality of life of patients.”
Xie, Z., Zhang, M., Luo, Y., Jin, D., Guo, X., Yang, W., Zheng, J., Zhang, H., Zhang, L., Deng, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0309 · Cited by 80
“Parkinson’s disease (PD) is the second leading neurodegenerative disease in the world, impacting more than 1.5% of people aged over 65 years, and its prevalence is expected to double by 2030 [1].”
Influential
Metadata
- Authors
- Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D.
- Venue
- Nature Reviews Disease Primers
- Published
- 2021-07-01
- Volume
- 7
- Issue
- 1
- Pages
- 47-47
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W3174664487
- Cited by
- 1,371
- References
- 291
- FWCI
- 27.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.